PMID- 1309045
OWN - NLM
STAT- MEDLINE
DCOM- 19931018
LR  - 20190616
IS  - 0077-8923 (Print)
IS  - 0077-8923 (Linking)
VI  - 667
DP  - 1992 Dec 4
TI  - The rationale of prevention of thrombosis by enhancing blood levels of 
      single-chain urokinase-type plasminogen activator (scuPA).
PG  - 278-80
FAU - Dooijewaard, G
AU  - Dooijewaard G
AD  - Gaubius Laboratory, IVVO-TNO, Leiden, The Netherlands.
FAU - van Boheemen, P A
AU  - van Boheemen PA
FAU - Binnema, D J
AU  - Binnema DJ
FAU - Kluft, C
AU  - Kluft C
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Ann N Y Acad Sci
JT  - Annals of the New York Academy of Sciences
JID - 7506858
RN  - EC 3.4.21.68 (Tissue Plasminogen Activator)
RN  - EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)
SB  - IM
MH  - Cardiovascular Diseases/complications/physiopathology
MH  - *Fibrinolysis
MH  - Humans
MH  - Models, Biological
MH  - Models, Cardiovascular
MH  - Thrombosis/*prevention & control
MH  - Tissue Plasminogen Activator/blood
MH  - Urokinase-Type Plasminogen Activator/*blood
EDAT- 1992/12/04 00:00
MHDA- 1992/12/04 00:01
CRDT- 1992/12/04 00:00
PHST- 1992/12/04 00:00 [pubmed]
PHST- 1992/12/04 00:01 [medline]
PHST- 1992/12/04 00:00 [entrez]
AID - 10.1111/j.1749-6632.1992.tb51625.x [doi]
PST - ppublish
SO  - Ann N Y Acad Sci. 1992 Dec 4;667:278-80. doi: 10.1111/j.1749-6632.1992.tb51625.x.